MORNING NEWS

S-Oil reported a nearly 23-fold increase in third-quarter net profit, driven by higher energy prices and wider refining margins amid uncertainty surrounding the prolonged Middle East conflict. The Saudi Aramco-controlled South Korean oil refiner said Monday that refining margins stayed firm in the July-September period, supported by tight supply due to the protracted Iran war.

Intel INTC shares plunged more than 20% in after-hours trading on Thursday after the company reported disappointing third-quarter results and forecasted a prolonged slowdown in personal-computer sales. Much of the pressure on the PC segment is coming from the persistently high price of memory chips, and the company expects that pressure to remain in 2028.

Samsung Electronics reported its fourth consecutive quarter of record earnings as its core semiconductor business continued to ride the AI-driven demand wave, though the results fell short of lofty expectations amid growing calls for higher shareholder returns.

South Korean memory chip giant SK Hynix plans to distribute a total of $75 billion to its shareholders this year. The company is benefiting massively from booming demand for hardware used in artificial intelligence (AI) applications. The world’s second-largest memory chip manufacturer reported another blockbuster set of results on Wednesday.

HSBC Holdings reported higher third-quarter net profit and announced a new share buyback of up to $1 billion. The London-based bank said Tuesday that net profit rose 45% from a year earlier to $7.09 billion for the three months ended Sept. 30. That still missed the estimate of $7.24 billion in a poll of analysts by data provider Visible Alpha.

Roche aims to make a pill developed by the Swiss pharmaceutical company a standard treatment for an advanced form of lung cancer. It marks the company’s first foray into an emerging field within the oncology market. Roche is working on several drugs that target a cancer driver that has long eluded the industry. A breakthrough in pancreatic cancer by the U.S. biotech company Revolution Medicines brought the field to investors’ attention, and Roche aims to enter this space with the lung cancer drug Divarasib.

At Holcim, revenue and operating profit grew significantly in the summer quarter. Overall, revenue increased by 15.5 percent to 4.66 billion Swiss francs from July through the end of September 2026, as Holcim announced on Friday. For the first time in a long while, the compa

Nestlé gained momentum in the third quarter of 2026. The world’s largest food company posted organic growth of 4.0 percent, up from 3.7 percent in the previous quarter. So-called real internal growth (RIG) reached 2.8 percent, as Nestlé announced on Thursday.

SpaceX SPCX and Tesla TSLA have formed special committees to discuss a potential merger, Elon Musk said Tuesday. Musk’s comments came toward the end of SpaceX’s quarterly earnings call in which executives said revenue more than doubled from a year earlier, and signaled more robust growth in the months ahead.

ABB continued to grow operationally in the third quarter of 2026. As in the first two quarters, revenue and order intake posted double-digit growth, with the latter performing exceptionally well, thanks in no small part to data centers.